The vital role of immunisation for disease prevention
Dr Ellie Cannon is joined by Sir Jonathan Van-Tam OBE, Former Deputy Chief Medical Officer for England, and Dr Gillian Ellsbury, Primary Care Medical Director at Pfizer UK to discuss the role of vaccination to help prevent infectious diseases and how this can potentially reduce pressures on the NHS.PP-UNP-GBR-10718 / November 2024
--------
33:46
What sickle cell disease tells us about health inequalities
Dr Ellie Cannon is joined by John James OBE, Chief Executive of the Sickle Cell Society and Seema Patel, Specialty Care Medical Director at Pfizer UK, to discuss health inequalities and explore what we can learn from the sickle cell community.PP-UNP-GBR-9699 / August 2024
--------
34:15
Understanding the impact of migraine
Dr Ellie Cannon is joined by Rob Music, CEO of The Migraine Trust and Gillian Ellsbury, Primary Care Medical Director at Pfizer UK, to explore the impact that migraine has on individuals and wider society.PP-UNP-GBR-8670 / April 2024
--------
34:54
Innovation in cancer: Defining the future of care
Dr Ellie Cannon is joined by Jane Lyons, CEO of Cancer52 and Stefano Podesta, Oncology Lead at Pfizer UK, to discuss the big challenges and opportunities in the fight against cancer within the UK. PP-UNP-GBR-7436 / November 2023
--------
42:58
Delivering a step forward for rare disease patients
Dr Ellie Cannon is joined by Dr. Jacqueline Barry, Chief Clinical Officer at the Cell and Gene Therapy Catapult and Owen Marks, Rare Disease Lead at Pfizer UK, to discuss the urgent need to evolve the way rare disease medicines are brought to patients, and why healthcare systems need to keep pace with scientific advancements.PP-UNP-GBR-6142 / August 2023
Healthcare in the modern world is changing rapidly. To help make sense of today’s challenges and tomorrow’s innovations, Dr Ellie Cannon invites Pfizer UK leaders and a variety of experts from across the pharmaceutical industry, life sciences and patient community to discuss the most pressing healthcare topics. Brought to you by Pfizer Ltd.
PP-UNP-GBR-10742 / November 2024
Ireland